These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17705402)

  • 1. Unusual regioselectivity and active site topology of human cytochrome P450 2J2.
    Lafite P; André F; Zeldin DC; Dansette PM; Mansuy D
    Biochemistry; 2007 Sep; 46(36):10237-47. PubMed ID: 17705402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression in yeast, new substrates, and construction of a first 3D model of human orphan cytochrome P450 2U1: Interpretation of substrate hydroxylation regioselectivity from docking studies.
    Ducassou L; Jonasson G; Dhers L; Pietrancosta N; Ramassamy B; Xu-Li Y; Loriot MA; Beaune P; Bertho G; Lombard M; Mansuy D; André F; Boucher JL
    Biochim Biophys Acta; 2015 Jul; 1850(7):1426-37. PubMed ID: 25857771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel substrates for human cytochrome P450 2J2.
    Lee CA; Neul D; Clouser-Roche A; Dalvie D; Wester MR; Jiang Y; Jones JP; Freiwald S; Zientek M; Totah RA
    Drug Metab Dispos; 2010 Feb; 38(2):347-56. PubMed ID: 19923256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Arginine 117 in Substrate Recognition by Human Cytochrome P450 2J2.
    Lafite P; André F; Graves JP; Zeldin DC; Dansette PM; Mansuy D
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30012976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinant of substrate binding and specificity of cytochrome P450 2J2.
    Xu L; Chen LY
    Sci Rep; 2020 Dec; 10(1):22267. PubMed ID: 33335233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
    Lee CA; Jones JP; Katayama J; Kaspera R; Jiang Y; Freiwald S; Smith E; Walker GS; Totah RA
    Drug Metab Dispos; 2012 May; 40(5):943-51. PubMed ID: 22328583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs.
    Mancy A; Antignac M; Minoletti C; Dijols S; Mouries V; Duong NT; Battioni P; Dansette PM; Mansuy D
    Biochemistry; 1999 Oct; 38(43):14264-70. PubMed ID: 10572000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential behavior of the sub-sites of cytochrome 450 active site in binding of substrates, and products (implications for coupling/uncoupling).
    Narasimhulu S
    Biochim Biophys Acta; 2007 Mar; 1770(3):360-75. PubMed ID: 17134838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of P450 3A4 SRS-2 residues on cooperativity and/or regioselectivity of aflatoxin B(1) oxidation.
    Xue L; Wang HF; Wang Q; Szklarz GD; Domanski TL; Halpert JR; Correia MA
    Chem Res Toxicol; 2001 May; 14(5):483-91. PubMed ID: 11368545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking.
    Li W; Tang Y; Liu H; Cheng J; Zhu W; Jiang H
    Proteins; 2008 May; 71(2):938-49. PubMed ID: 18004755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes.
    Hashizume T; Imaoka S; Mise M; Terauchi Y; Fujii T; Miyazaki H; Kamataki T; Funae Y
    J Pharmacol Exp Ther; 2002 Jan; 300(1):298-304. PubMed ID: 11752129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity.
    Lee SS; Jeong HE; Liu KH; Ryu JY; Moon T; Yoon CN; Oh SJ; Yun CH; Shin JG
    Pharmacogenet Genomics; 2005 Feb; 15(2):105-13. PubMed ID: 15861034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.
    Lee E; Wu Z; Shon JC; Liu KH
    Drug Metab Dispos; 2015 Aug; 43(8):1250-3. PubMed ID: 26048912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The substrate binding site of human liver cytochrome P450 2C9: an approach using designed tienilic acid derivatives and molecular modeling.
    Mancy A; Broto P; Dijols S; Dansette PM; Mansuy D
    Biochemistry; 1995 Aug; 34(33):10365-75. PubMed ID: 7654690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6.
    Yumibe N; Huie K; Chen KJ; Snow M; Clement RP; Cayen MN
    Biochem Pharmacol; 1996 Jan; 51(2):165-72. PubMed ID: 8615885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical intermediates in the catalytic oxidation of hydrocarbons by bacterial and human cytochrome P450 enzymes.
    Jiang Y; He X; Ortiz de Montellano PR
    Biochemistry; 2006 Jan; 45(2):533-42. PubMed ID: 16401082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The substrate binding site of human liver cytochrome P450 2C9: an NMR study.
    Poli-Scaife S; Attias R; Dansette PM; Mansuy D
    Biochemistry; 1997 Oct; 36(42):12672-82. PubMed ID: 9335524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro.
    Chang SY; Li W; Traeger SC; Wang B; Cui D; Zhang H; Wen B; Rodrigues AD
    Drug Metab Dispos; 2008 Dec; 36(12):2513-22. PubMed ID: 18787056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions.
    Yamazaki H; Gillam EM; Dong MS; Johnson WW; Guengerich FP; Shimada T
    Arch Biochem Biophys; 1997 Jun; 342(2):329-37. PubMed ID: 9186495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.
    Tang C; Shou M; Mei Q; Rushmore TH; Rodrigues AD
    J Pharmacol Exp Ther; 2000 May; 293(2):453-9. PubMed ID: 10773015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.